ANTI-ATHEROSCLEROTIC EFFECT OF ROSUVASTATIN BY
MODULATION OF MGF-E8 AND KLOTHO EXPRESSION
DEYONG YUE 1, YUNDA JIANG 1, LIANG CAO 2, HAIYING SHEN 3, ZHONGYING YANG 1*
1Department of Pharmacy, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Chong Ming
Branch, Shanghai, 202150, China
2Department of Information, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Chong Ming
Branch, Shanghai, 202150, China
3Graduate School, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China
*corresponding author: yangzhongying_01@sina.com
Download Full Article

Abstract:
The aim of this study was to assess the effect of rosuvastatin-mediated MFG-E8 expression on the symptoms of Coronary
Heart Disease (CHD) patients with hyperlipidaemia. Two hundred CHD patients with hyperlipidaemia who were admitted to
Chong Ming Branch, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, China between 2015
and 2017 were selected and divided into two groups. The subjects in the control group received Hypocol® treatment, while
those in the experimental group were additionally treated with rosuvastatin 10 mg/day. After 6 weeks of treatment, the
differences of low density lipoprotein cholesterol (LDL-C), high sensitive C-reactive protein (hs-CRP), lipoprotein-a (LP
(a)), high density lipoprotein cholesterol (HDL-C), MFG-E8, Klotho protein expression and the levels of Th1 and Th2 cell in
peripheral blood were assessed. Our results showed that MFG-E8, Klotho protein and HDL-C were higher compared to the
control group (p < 0.05). The levels of Th1 cells in both groups decreased, while the levels of Th2 increased. Therefore
rosuvastatin can act by altering the expression levels of related proteins, such as MFG-E8 and Klotho and by modifying the
levels of Th1/Th2 cells.

Top